FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase
- 21 October 2021
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 286, 120072
- https://doi.org/10.1016/j.lfs.2021.120072
Abstract
No abstract availableKeywords
Funding Information
- Khon Kaen University (PCO-793)
- Thailand Research Fund
- Thailand Research Fund (DBG5980004)
This publication has 40 references indexed in Scilit:
- Chemotherapy for cholangiocarcinoma: An updateWorld Journal of Gastrointestinal Oncology, 2013
- Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathwayNeuro-Oncology, 2011
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerThe New England Journal of Medicine, 2010
- FoxM1 Is a General Target for Proteasome InhibitorsPLOS ONE, 2009
- Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer CellsPLOS ONE, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- 5-Fluorouracil: Mechanisms of Resistance and Reversal StrategiesMolecules, 2008
- Intrahepatic CholangiocarcinomaAnnals of Surgery, 2008
- Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1Cancer Research, 2006
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006